Biotech

All Articles

J &amp J drops stage 2 dengue candidate in most recent switch coming from vaccinations

.Johnson &amp Johnson's deprioritization of its contagious disease pipe has claimed an additional su...

Relay drops 10% of team after earlier cutbacks in July

.Precision medicine biotech Relay Therapeutics is dropping about 10% of its staff in attempts to str...

Pentixapharm credit ratings $22M IPO to advance radiopharma trials

.Pentixapharm has actually introduced practically 20 thousand europeans ($ 22 million) coming from a...

Lundbeck water faucets Charles River for AI-enabled neuro medication breakthrough

.Lundbeck has actually tapped Charles River Laboratories' expert system capacities to aid the findin...

Big pharma, biotech 'won't necessarily be symbiotic' in AI: S&ampP

.Large Pharma is actually putting in intensely in artificial intelligence to reduce development time...

I &amp I biotech Triveni increases $115M for preclinical antitoxins

.Triveni Bio has trapped $115 million in series B funds to accelerate preclinical antibody programs ...

IGM turns from cancer cells to autoimmune, agitating C-suite

.IGM Biosciences ended last year laying off staff as well as improving its cancer pipe. Now, the bus...

Shattuck centers CD47 program over unstable efficiency data, gives up 40% of staff and sheds Ono work

.Shattuck Labs has actually pounded one more nail right into the casket of CD47. After finding a "re...

BioMarin goes CAMPing, striking RNA manage biotech

.BioMarin is actually incorporating firewood to the R&ampD fire, attacking a complement along with C...

Cash- strapped Gritstone begins look for strategic options as cancer cells injection information underwhelm

.Gritstone biography has generated bankers to check out "prospective value-maximizing techniques" af...